utility of urinary [timp-2]*[igfbp7] as a predictor of
TRANSCRIPT
#2
77
2 R
ev. 0
1/1
7
Utility of Urinary [TIMP-2]*[IGFBP7]as a Predictor of Acute Kidney Injury
in Cardiac Surgery Patients
Paul L. DiGiorgi, MD, FACSShipley Cardiothoracic Center
HealthPark Medical CenterFort Myers, Florida
Association of Physician Assistants in
Cardiothoracic and Vascular Surgery37th Annual Meeting
April 2018
#2
77
2 R
ev. 0
1/1
7
Disclosures:
None
Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Inter, Suppl. 2012; 2:1-138Tolwani A. Continuous Renal-Replacement Therapy for Acute Kidney Injury. N Engl J Med. 2012;367:2505-2514.
What is Acute Kidney Injury?
Acute injury with associated functional decrease.
Relatively Common in Cardiac Surgery
[1] Mehta et al. Circuation 2006[2] Lagny MG et al, BMC Nephrology. 2015;16:76[3] Hobson et al. Circulation. 2009;119:2444-2453
• Published AKI rates2,3: ~50%
• STS renal failure rate1: 1-5%
• Associated with significant complications:
• Death
• Stroke
• Bleeding
• Pneumonia
• Wound infection
• Multisystem organ failure
• Length of stay / Readmission
• Costly
Worse Long Term Survival afterCardiac Surgery
Hobson et al. Circulation. 2009;119:2444-2453
Worse Survival even with Recovery
Hobson et al. Circulation. 2009;119:2444-2453
Readmission Rates after Cardiac Surgery
Brown JR et al. Impact of perioperative acute kidney injury as a severity index for thirty-day readmission after cardiac surgery. Ann Thorac Surg. 2014;97(1):111-7.
N=2,209
* AKI by creatinine definition
Financial Impact of AKI after Cardiac Surgery
Alshaikh, HN et al. Ann Thorac Surg 2018 Feb;105(2):469-475
• 2008 – 2011 National Inpatient Sample database• CABG and/or valve replacement operations• AKI captured by ICD diagnosis• Total patients: 1,267,383• AKI rate about 10%
Financial Impact of AKI after Cardiac Surgery
Alshaikh, HN et al. Ann Thorac Surg 2018 Feb;105(2):469-475
• 2008 – 2011 National Inpatient Sample database• CABG and/or valve replacement operations• AKI captured by ICD diagnosis• Total patients: 1,267,383• AKI rate about 10%
Risk Factors
O’Neal et al. Critical Care (2016) 20;187
Can Early Identification Stop Progression?
Figure adapted from: [1] Lewington AJP, Certa J, Mehta RL Raising Awareness of Acute Kidney Injury: A Global Perspective of a Silent Killer. Kidney Int. 2013;84(3):457-467.[19] Kellum JA, Chawla LS. Cell-Cycle Arrest and acute kidney injury: the light and dark sides. Nephrol Dial Transplant. 2016;1:16-22
Kidney stress is a precursor for AKI19
Discovery & Validation of [TIMP-2]*[IGFBP7]Nephrocheck (NC)
[27] Kashani K, et al. Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care.
2013;17:R25.
[28] Bihorac A, et al. Validation of Cell-Cycle Arrest Biomarkers for Acute Kidney Injury Using Clinical Adjudication. Am J
Respir Crit Care Med. 2014;189(8):932-939.
Use and Intervention associated with lower rates of AKI
Meersch et al. 2017. Intensive Care Med : Prevention of cardiac surgery-associated AKI by implementing the
KDIGO guidelines in high risk patients identified by biomarkers: the PrevAKI randomized controlled trial.
N=276
HealthPark Study
• September 2015 – October 2016• Cardiac surgery patients only, ESRD excluded• Baseline creatinine = closest to OR (STS)• NC drawn 4-12 hrs after entry into OHICU• Peak creatinine @ 24 hrs postop• Peak creatinine recorded for hospitalization• Hourly UO recorded while in ICU• KDIGO guideline management on all patients
Methods
• NC recorded, considered positive for > 0.3• AKI determined per KDIGO guidelines• Calculated STS RF rate, O:E ratio• Compared AKI rates before and after NC begun• NC results report all cases• Risk scores, outcomes reported from STS db
Results
Total patients: 1116 (STS+TVT), STS 1015
Male (%) 73
BMI 29
Age (years) 69
Diabetic (%) 41
HTN (%) 85
Baseline creatinine (Crs) 1.14
Emergent (%) 4
CPB (min) 106
Aortic crossclamp (min) 77
Isolated CABG (%) 50
TAVR (%) 12
Transfusion (%) 40
Results
No AKI (673) AKIany (342) p-Values
30-Day Mortality (%) 2.8 5.3 0.07
Length of Stay (days) 6.7 7.8 <0.01
Readmission (%) 16.9 19.3 0.36
N=1,015*
*STS Adult Cardiac Database
NC level AKIany AKICr
+NC = 2.0+ 50% 23%
+NC 1.4-1.99 30% 5%
+NC 0.31-1.39 18% 4.7%
Higher NC levels increase likelihood of AKI
N=1,116
PPV of AKI at different NC levels
The Negative NC
Negative predictive value for any AKI: 77%
0
20
40
60
80
100
120
AKI
False Negative NC
Total UO only UO/Cr @ 24hr UO/Cr LOS
• *When drawn at 24 hours• Vast majority were diagnosed by UO only
Creatinine may be better than UOin Cardiac Surgery Patients
Lagny et al. BMC Nephrology (2015) 16:76
N=443
Results: RF and AKI
AKI (UO & Cr @24hr) AKI (UO & Crpeak)
AKI (all) (n, %) 343, 31% 373, 34%
AKI stage 1 (n, %) 178, 16% 193, 17%
AKI stage 2 (n, %) 152, 14% 165, 15%
AKI stage 3 (n, %) 13, 1% 22, 2%
Observed Expected O:E
Renal Failure Risk(Isolated CABG, STS)
0.35% 4.25% 0.08
Results: NC implementation impact*
Pre NC (863) Post NC (1116) p-Value
All creat AKI (n, %) 88, 10% 77, 7% 0.01
AKI stage 1 (n, %) 45, 5% 45, 4%
AKI stage 2 (n, %) 25, 3% 20, 2%
AKI stage 3 (n, %) 18, 2% 12, 1%
Renal Failure Expected Risk (STS)
4.9% 4.7%
*AKI defined by creatinine change only
0.0%
1.0%
2.0%
3.0%
4.0%
5.0%
6.0%
Stage 1 AKI Stage 2 AKI Stage 3 AKI
Pe
rce
nt
of
card
iac
surg
ery
pat
ien
ts
Pre-NephroCheck(N=863)
Post-NephroCheck(N = 1116)
22.7%reduction
38.1%reduction
48.4%reduction
p = 0.01 for reduction of combined stage 1,2,3 AKI (32.3% reduction)
Data presented at Multidisciplinary Cardiovascular and Thoracic Critical Care Conference, 10/6/17
BigPAK RCT NephroCheck-Indicated KDIGO Protocol
Median ICU LOS decreased by 1 day (p = 0.035)P
rop
ort
ion
of
pat
ien
ts r
emai
nin
g in
th
e IC
U (
%)
Days in ICU
Proportion of patients remaining in ICU
Control (Standard care)
Intervention
0%
5%
10%
15%
20%
25%
Control Intervention
Pati
ents
Wit
h M
od
erat
e-Se
vere
AK
I Wit
hin
7 D
ays
(%)
Moderate-Severe AKI (7 days)
66.1% reductionp = 0.035
Göcze I, Jauch D, Götz M, et al. Biomarker-guided intervention to prevent acute kidney injury after major surgery: the prospective randomized BiK Study. Ann Surg. Published online August 2017.
• 66% Reduction In Stage 2-3• ICU LOS Reduction• >$2000 Cost Savings per patient
PrevAKI RCT NephroCheck-Indicated KDIGO Protocol
Using Stress Biomarkers to Avoid AKI
• Avoidance of early ACEI/ARBs, toradol
• Glycemic control
• Optimizing hemodynamics
• Potential slow weaning of drips, delayed transfer from ICU
• Perioperative vancomycin dosing adjustment
• Start diuretics > 24 hours
Postoperative Management
Good UO/hemodynamics
Typical Case Scenarios
MarginalUnstable / on
significant support
+ NC - NC + NC - NC
Transfer out Transfer out
Delay transfer, optimize
• AKI has long term implications even if creatinine normalizes
• Early urine output importance unclear in postop patient
• Outcomes are becoming more and more scrutinized
• AKI potentially avoidable with early stress identification
• Biomarkers may be helpful if properly interpreted and acted upon
• Preoperative optimization impacts postoperative outcomes
Conclusions
Thank You